Delayed
Nyse
12:00:15 2024-07-09 pm EDT
|
5-day change
|
1st Jan Change
|
5.18
USD
|
+3.39%
|
|
-2.26%
|
-32.11%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,162
|
407.8
|
60.66
|
41.05
|
-
|
Enterprise Value (EV)
1 |
1,062
|
232.3
|
60.66
|
-193.1
|
41.05
|
P/E ratio
|
-1.14
x
|
-0.27
x
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.54
x
|
0.17
x
|
0.05
x
|
0.04
x
|
0.04
x
|
EV / Revenue
|
0.26
x
|
0.1
x
|
0.05
x
|
-0.19
x
|
0.04
x
|
EV / EBITDA
|
-0.98
x
|
-0.99
x
|
-7.15
x
|
-7.41
x
|
1.07
x
|
EV / FCF
|
20,568,053
x
|
1,121,774
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
-
|
Price to Book
|
1.89
x
|
-2.03
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
7,857
|
7,844
|
7,951
|
8,193
|
-
|
Reference price
2 |
275.2
|
51.99
|
7.630
|
5.010
|
5.010
|
Announcement Date
|
3/2/22
|
3/1/23
|
3/6/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
4,029
|
2,412
|
1,161
|
1,005
|
1,135
|
EBITDA
1 |
-
|
-1,081
|
-233.5
|
-8.48
|
26.04
|
38.4
|
EBIT
1 |
-
|
-1,198
|
-622.2
|
-577
|
-103.1
|
-49
|
Operating Margin
|
-
|
-29.74%
|
-25.8%
|
-49.71%
|
-10.26%
|
-4.32%
|
Earnings before Tax (EBT)
|
-
|
-1,205
|
-634.3
|
-
|
-
|
-
|
Net income
|
-248.4
|
-1,185
|
-1,495
|
-
|
-
|
-
|
Net margin
|
-
|
-29.41%
|
-61.99%
|
-
|
-
|
-
|
EPS
|
-437.6
|
-241.6
|
-190.4
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
51.64
|
207.1
|
-
|
-
|
-
|
FCF margin
|
-
|
1.28%
|
8.58%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/18/21
|
3/2/22
|
3/1/23
|
3/6/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
962.3
|
1,836
|
1,577
|
1,632
|
551.4
|
756.3
|
747.7
|
269.4
|
292.9
|
245.1
|
257.2
|
241.2
|
261.6
|
EBITDA
1 |
-790.1
|
-74.83
|
-194.9
|
-82.93
|
-108.5
|
-35.05
|
6.413
|
1.205
|
-10.36
|
2.529
|
13.5
|
11.8
|
-8.6
|
EBIT
1 |
-820
|
-177
|
-248.1
|
-252.7
|
-186.1
|
-85.75
|
-23.41
|
-462.8
|
-45.94
|
-23.1
|
-9
|
-10.5
|
-30.7
|
Operating Margin
|
-85.21%
|
-9.64%
|
-15.74%
|
-15.48%
|
-33.74%
|
-11.34%
|
-3.13%
|
-171.78%
|
-15.68%
|
-9.43%
|
-3.5%
|
-4.35%
|
-11.74%
|
Earnings before Tax (EBT)
|
-821.7
|
-177.4
|
-248.4
|
-257.6
|
-192.5
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-814.5
|
-204.2
|
-284.1
|
-315.8
|
-691.2
|
-186.9
|
-125
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-84.64%
|
-11.12%
|
-18.02%
|
-19.34%
|
-125.34%
|
-24.71%
|
-16.72%
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-103.2
|
-25.60
|
-36.00
|
-40.00
|
-88.00
|
-24.00
|
-15.70
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/2/22
|
5/4/22
|
8/10/22
|
11/9/22
|
3/1/23
|
5/9/23
|
8/9/23
|
11/7/23
|
3/6/24
|
5/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,100
|
176
|
-
|
234
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
51.6
|
207
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-369%
|
-317%
|
-
|
32.3%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-43.8%
|
-36.2%
|
-
|
-8.65%
|
-
|
Assets
|
-
|
2,705
|
4,132
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
146.0
|
-25.60
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
16.70
|
29.90
|
-
|
-
|
-
|
Capex
|
-
|
30.4
|
27.4
|
-
|
-
|
-
|
Capex / Sales
|
-
|
0.75%
|
1.14%
|
-
|
-
|
-
|
Announcement Date
|
3/18/21
|
3/2/22
|
3/1/23
|
3/6/24
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
5.01
USD Average target price
8
USD Spread / Average Target +59.68% Consensus |
1st Jan change
|
Capi.
|
---|
| -32.11% | 41.05M | | +7.26% | 76.34B | | +8.18% | 50.3B | | +26.62% | 48.37B | | +14.55% | 42.03B | | +23.00% | 40.04B | | +21.57% | 33.49B | | -2.28% | 28.51B | | +35.74% | 28.14B | | -9.44% | 27.07B |
Other Life & Health Insurance
|